Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

Keyphrases

• Type 2 Diabetic Patients 100%
• Insulin Dose 100%
• Basal Insulin 100%
• Type 2 Diabetes Mellitus (T2DM) 75%
• Quality of Life 50%
• Hemoglobin A1c (HbA1c) 50%
• Training Program 25%
• Clinical Practice 25%
• Clinical Setting 25%
• Glycemic Control 25%
• Clinical Variables 25%
• Body Mass Index 25%
• Glycated Hemoglobin 25%
• Single-center Study 25%
• Single Episode 25%
• Diabetes Duration 25%
• Glargine 25%
• Lipid Parameters 25%
• Biochemical Variables 25%
• Low-density Lipoprotein Particle 25%
• Rapid-acting Insulin 25%
• Basal-bolus Regimen 25%
• Blood Glucose Control 25%
• Total Daily Insulin Dose 25%
• Diabetes Training 25%
• Severe Hypoglycemia 25%

Nursing and Health Professions

• Insulin Treatment 100%
• Maturity Onset Diabetes of the Young 100%
• Clinical Practice 66%
• Hemoglobin A1c 66%
• Quality of Life 66%
• Body Mass 33%
• Glycosylated Hemoglobin 33%
• Practice Setting 33%
• Outpatient 33%
• Low Density Lipoprotein 33%
• Blood Glucose Monitoring 33%
• Hypoglycemia 33%
• Body Weight 33%
• Short Acting Insulin 33%
• Efficacy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Hemoglobin A1c 100%
• Maturity Onset Diabetes of the Young 100%
• Low Density Lipoprotein 50%
• Glycosylated Hemoglobin 50%
• Hypoglycemia 50%
• Short Acting Insulin 50%
• Insulin Analog 50%